Ancient Chinese Herbal Formula Extends Worm Lifespan via Cellular Aging Pathways
Liu Jun Zi Decoction, a traditional Chinese herbal formula, extends lifespan and boosts stress resistance in C. elegans through p16/p21 and IIS/mTOR signaling.
Resumen
Researchers tested Liu Jun Zi Decoction (LJZD), a centuries-old Chinese herbal formula, in C. elegans worm models and found it extended lifespan while improving stress resistance and movement. Using serum pharmacochemistry and network pharmacology, they identified bioactive compounds targeting two key aging pathways: IIS/mTOR and p16/p21. LJZD also improved mitochondrial function and offered neuroprotection in worm models expressing Alzheimer's-related proteins amyloid-beta and tau. The findings suggest multi-target herbal interventions may offer a promising, natural strategy for combating aging and neurodegeneration.
Resumen detallado
Age-related decline is one of the defining health challenges of our time, driving intense interest in safe, natural interventions that can slow biological aging. Traditional Chinese medicine, with its long history of multi-ingredient herbal formulas, represents an underexplored reservoir of potential longevity compounds.
This study examined Liu Jun Zi Decoction (LJZD), a classical Chinese herbal formula, using Caenorhabditis elegans — a widely validated model organism in aging research due to its short lifespan, genetic tractability, and conserved aging pathways. Researchers measured lifespan, locomotion, and stress resistance across treated and untreated worm populations.
LJZD significantly extended lifespan and improved healthspan markers including physical movement and resilience under stress conditions. The team employed serum pharmacochemistry, network pharmacology, and molecular docking to pinpoint the formula's key bioactive constituents and their molecular targets. These analyses identified the IIS/mTOR and p16/p21 pathways as central mediators of LJZD's anti-aging effects. Mitochondrial function was also improved via IIS-mTOR axis modulation, supporting cellular energy metabolism in aged worms.
Strikingly, LJZD demonstrated neuroprotective effects in C. elegans models engineered to express amyloid-beta and tau — proteins central to Alzheimer's disease pathology. This suggests the formula may have relevance beyond general aging, potentially impacting neurodegenerative disease progression.
However, key caveats apply. C. elegans, while powerful, differs substantially from mammalian biology, and translation to humans remains unproven. The study's reliance on network pharmacology and molecular docking, rather than direct biochemical validation of each compound, limits mechanistic certainty. Clinical studies will be essential before any therapeutic recommendations can be made.
Hallazgos clave
- LJZD extended lifespan and improved locomotion and stress resistance in C. elegans worm models.
- Network pharmacology and molecular docking identified IIS/mTOR and p16/p21 pathways as key LJZD targets.
- LJZD improved mitochondrial function via IIS-mTOR axis modulation in aging worms.
- LJZD provided neuroprotection in C. elegans models expressing Alzheimer's-linked amyloid-beta and tau proteins.
- Serum pharmacochemistry identified specific bioactive compounds responsible for anti-aging effects.
Metodología
The study used Caenorhabditis elegans as a model organism to assess lifespan, stress resistance, and locomotion following LJZD treatment. Serum pharmacochemistry, network pharmacology, and molecular docking were combined to identify bioactive compounds and pathway targets. Neuroprotective effects were evaluated in transgenic worm strains expressing amyloid-beta and tau proteins.
Limitaciones del estudio
C. elegans is a simple invertebrate with significant biological differences from humans, limiting direct translational applicability. Network pharmacology and molecular docking are computational tools that require wet-lab validation for each proposed compound-target interaction. No mammalian or clinical data are presented, so efficacy and safety in humans remain entirely unknown.
¿Te ha gustado este resumen?
Recibe la última investigación sobre longevidad en tu bandeja de entrada cada semana.
Introduce tu correo electrónico para suscribirte: